Acumen Pharmaceuticals, Inc. (ABOS)
Largest Insider Buys in Sector
ABOS Stock Price History Chart
ABOS Stock Performance
About Acumen Pharmaceuticals, Inc.
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.
Insider Activity of Acumen Pharmaceuticals, Inc.
Over the last 12 months, insiders at Acumen Pharmaceuticals, Inc. have bought $0 and sold $121,677 worth of Acumen Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at Acumen Pharmaceuticals, Inc. have bought $49.68M and sold $197,005 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 5,161,290 shares for transaction amount of $40M was made by RA CAPITAL MANAGEMENT, L.P. () on 2023‑07‑21.
List of Insider Buy and Sell Transactions, Acumen Pharmaceuticals, Inc.
| 2024-01-19 | Sale | President and CEO | 15,200 0.0253% | $3.47 | $52,753 | -15.63% | ||
| 2024-01-19 | Sale | Chief Legal Officer & Corp Sec | 8,933 0.0149% | $3.48 | $31,048 | -15.63% | ||
| 2024-01-18 | Sale | CFO & Chief Business Officer | 4,242 0.0075% | $3.71 | $15,717 | -16.01% | ||
| 2024-01-18 | Sale | Chief Medical Officer | 3,124 0.0055% | $3.71 | $11,604 | -16.01% | ||
| 2024-01-18 | Sale | Chief Operating Officer | 2,833 0.005% | $3.73 | $10,555 | -16.01% | ||
| 2023-08-17 | Sale | director | 41,949 0.0739% | $6.49 | $272,334 | -46.80% | ||
| 2023-07-21 | 5.16M 13.1759% | $7.75 | $40M | -51.62% | ||||
| 2021-07-06 | 1.88M 3.8811% | $16.00 | $30M | -67.95% | ||||
| 2021-07-06 | 10 percent owner | 1.06M 2.1993% | $16.00 | $17M | -67.95% | |||
| 2021-07-06 | 10 percent owner | 450,000 0.8663% | $14.88 | $6.7M | -67.95% | |||
| 2021-07-06 | 10 percent owner | 312,500 0.6468% | $16.00 | $5M | -67.95% | |||
| 2021-07-06 | director | 35,000 0.0724% | $16.00 | $560,000 | -67.95% | |||
| 2021-07-06 | director | 6,250 0.0129% | $16.00 | $100,000 | -67.95% |
Insider Historical Profitability
| RA CAPITAL MANAGEMENT, L.P. | 13043179 21.7098% | $1.85 | 2 | 0 | <0.0001% | |
| Hardie Robert D. | 10 percent owner | 3951156 6.5765% | $1.85 | 1 | 0 | <0.0001% |
| Sands Capital Ventures Discovery Fund III, L.P. | 10 percent owner | 3417075 5.6876% | $1.85 | 1 | 0 | <0.0001% |
| Manning Paul B | 10 percent owner | 3352693 5.5804% | $1.85 | 1 | 0 | <0.0001% |
| Stalfort John A III | director | 172324 0.2868% | $1.85 | 1 | 0 | <0.0001% |
Institutional Investor Ownership
| RA Capital Management, L.P. | $60.47M | 24.85 | 14.93M | 0% | +$0 | 0.06 | |
| Sands Capital Ventures LLC | $13.84M | 5.69 | 3.42M | 0% | +$0 | 3.34 | |
| Franklin Templeton Investments | $13.75M | 5.65 | 3.4M | +1.09% | +$148,266.45 | <0.01 | |
| Millennium Management LLC | $10.65M | 4.38 | 2.63M | +75.86% | +$4.59M | 0.01 | |
| ROCK SPRINGS CAPITAL MANAGEMENT, LP | $9.32M | 3.83 | 2.3M | 0% | +$0 | 0.24 |